Compounds > zm 241385
Page last updated: 2024-09-05

zm 241385 and 2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide

zm 241385 has been researched along with 2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide in 3 studies

Compound Research Comparison

Studies
(zm 241385)		Trials
(zm 241385)		Recent Studies (post-2010)
(zm 241385)		Studies
(2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide)		Trials
(2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide)		Recent Studies (post-2010) (2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide)
4013124158252

Protein Interaction Comparison

ProteinTaxonomyzm 241385 (IC50)2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide (IC50)
Adenosine receptor A3Homo sapiens (human)0.0017

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, ZG; Jacobson, KA1
Federico, S; Jacobson, KA; Jayasekara, PS; Kozma, E; Moro, S; Paoletta, S; Spalluto, G; Squarcialupi, L1
Auchampach, JA; Ge, ZD; Gross, GJ; Jacobson, MA; Kreckler, LM; Peart, JN; Wan, TC1

Reviews

2 review(s) available for zm 241385 and 2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide

ArticleYear
Adenosine receptors as therapeutic targets.
    Nature reviews. Drug discovery, 2006, Volume: 5, Issue:3

    Topics: Animals; Disease; Drug Therapy; Humans; Ligands; Molecular Structure; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction; Structure-Activity Relationship

2006
Fluorescent ligands for adenosine receptors.
    Bioorganic & medicinal chemistry letters, 2013, Jan-01, Volume: 23, Issue:1

    Topics: Boron Compounds; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Ligands; Protein Binding; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1

2013

Other Studies

1 other study(ies) available for zm 241385 and 2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide

ArticleYear
Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor.
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 319, Issue:3

    Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Blood Pressure; Cardiotonic Agents; Cell Degranulation; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Histamine; In Vitro Techniques; Male; Mice; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; p-Methoxy-N-methylphenethylamine; Pyridines; Radioligand Assay; Receptor, Adenosine A3; Triazines; Triazoles

2006